Category

UF Startup

AavantiBio and Resilience Announce Strategic Collaboration for Gene Therapy Development and Manufacturing

UF startup and UF Innovate | The Hub resident AavantiBio, a gene therapy company focused on transforming the lives of patients with rare genetic diseases, and National Resilience, Inc. (Resilience), a company building the world’s most advanced biopharmaceutical manufacturing ecosystem and who recently acquired UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices, announced a strategic collaboration to support the development and manufacturing of AavantiBio’s pipeline of therapies, including its lead program in Friedreich’s Ataxia (FA).

AGTC Breaks Ground on New Biotech Lab in Alachua

Applied Genetic Technologies Corporation will build a new 21,000 square foot laboratory facility in Alachua. The facility will include control labs and a manufacturing suite and will add 50 jobs.

Enagás and SATLANTIS Start Microsatellite Camera Calibration Tests To Detect Emissions

Enagás and SATLANTIS, a UF startup and UF Innovate | The Hub resident company specializing in high-performance optical loads for observation of the Earth for small satellites, are carrying out high-precision optics calibration tests, which will be inserted into a constellation of space microsatellites, known by the acronym GEISAT (Greenhouse Gases), to detect and quantify methane emissions on Earth.

AGTC Announces Expansion of Manufacturing and Analytics Capabilities to Advance Commercialization of Gene Therapy Product Candidates

UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced that it has initiated plans to lease a build-to-suit 21,000 square foot current Good Manufacturing Practices (cGMP) manufacturing and quality control facility adjacent to its Florida facility to prepare for anticipated late-stage development of its X-Linked Retinitis Pigmentosa (XLRP) and Achromatopsia (ACHM) programs.